Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Saori Yamada‐Kanazawa"'
Autor:
Kenichiro TANAKA, Ikko KAJIHARA, Kazuro SHIMOKAWA, Naotoshi NAKAMURA, Yudo KUSABA, Ryoko SAKAMOTO, Saki MAEDA-OTSUKA, Saori YAMADA-KANAZAWA, Soichiro SAWAMURA, Hisashi KANEMARU, Katsunari MAKINO, Jun AOI, Shinichi MASUGUCHI, Takashi SUZUKI, Satoshi FUKUSHIMA
Publikováno v:
European Journal of Dermatology; mar/apr2024, Vol. 34 Issue 2, p182-192, 93p
Autor:
Saori Yamada-Kanazawa1, Shuichi Shimada1, Wakana Nakayama1, Soichiro Sawamura1, Yuki Nishimura1, Ikko Kajihara1, Katsunari Makino1, Jun Aoi1, Shinichi Masuguchi1, Fukiko Amano2, Satoshi Fukushima1
Publikováno v:
Drug Discoveries & Therapeutics. Feb2023, Vol. 17 Issue 1, p70-72. 3p.
Autor:
Takehiro Ohnuma, Myangat Tselmeg Mijiddorj, Ikko Kajihara, Soichiro Sawamura, Ryoko Sakamoto, Saki Maeda‐Otsuka, Saori Yamada‐Kanazawa, Katsunari Makino, Jun Aoi, Shinichi Masuguchi, Satoshi Fukushima
Publikováno v:
The Journal of Dermatology.
Autor:
Yudo Kusaba, Ikko Kajihara, Tselmeg Mijiddorj Myangat, Kenichiro Tanaka, Ryoko Sakamoto, Saki Maeda‐Otsuka, Saori Yamada‐Kanazawa, Soichiro Sawamura, Hisashi Kanemaru, Yuki Nishimura, Kayo Nakamura‐Kashiwada, Katsunari Makino, Azusa Miyashita, Jun Aoi, Shinichi Masuguchi, Satoshi Fukushima
Publikováno v:
The Journal of Dermatology. 49:508-514
Although the prognosis of patients with extramammary Paget's disease (EMPD) treated with radical resection is good, the prognosis of EMPD with distant metastasis is very poor. PIK3CA mutations predict a good response to PIK3CA inhibitors. The aim of
Autor:
Soichiroa Sawamura, Myangat Tselmeg Mijiddorj, Ikko Kajihara, Shuichi Shimada, Hisashi Kanemaru, Saori Yamada‐Kanazawa, Katsunari Makino, Jun Aoi, Shinichi Masuguchi, Satoshi Fukushima
Publikováno v:
Journal of the European Academy of Dermatology and Venereology. 37
Publikováno v:
Drug Discoveries & Therapeutics. 16:254-255
Nevus of Ota is a dermal melanocytosis that consists of blue-brown spots, patches and plaques along the distribution of the first and second branches of trigeminal nerve. The efficacy of Q-switched ruby laser treatment against nevus of Ota on dark sk
Autor:
Yudo Kusaba, Saori Yamada-Kanazawa, Jun Aoi, Katsunari Makino, Ikko Kajihara, Saki Maeda-Otsuka, Satoshi Fukushima, Shinichi Masuguchi, Soichiro Sawamura, Ryoko Sakamoto
Publikováno v:
The Journal of dermatologyREFERENCES. 48(10)
Autor:
Saki Maeda-Otsuka, Saori Yamada-Kanazawa, Katsunari Makino, Ikko Kajihara, Hironobu Ihn, Shinichi Masuguchi, Soichiro Sawamura, Ryoko Sakamoto, Tselmeg Mijiddorj Myangat, Satoshi Fukushima
Publikováno v:
The Journal of dermatologyReferences. 48(8)
Autor:
Soichiro Sawamura, Satoshi Fukushima, Saki Otsuka-Maeda, Katsunari Makino, Shinichi Masuguchi, Yuki Nishimura, Hisashi Kanemaru, Takamitsu Makino, Myangat Tselmeg Mijiddorj, Saori Yamada-Kanazawa, Jun Aoi, Ikko Kajihara, Ryoko Sakamoto, Hironobu Ihn
Publikováno v:
Japanese journal of clinical oncology. 51(7)
Extramammary Paget’s disease is a rare malignant tumor of the skin that occurs primarily in the genitocrural region. Although the prognosis of extramammary Paget’s disease with distant metastasis is poor, an effective therapy has not been establi
Autor:
Satoshi Fukushima, Hironobu Ihn, Toshikatsu Igata, Saki Maeda-Otsuka, Saori Yamada-Kanazawa, Jun Aoi, Ikko Kajihara, Shinichi Masuguchi, Yuki Nakamura, Masatoshi Jinnin, Takamitsu Johno
Publikováno v:
Drug Discoveries & Therapeutics. 11:152-155
S-1, a 5-fluorouracil (5-FU)-based anti-cancer agent, is an important drug for treating metastatic extramammary Paget's disease (EMPD). Although intratumor expression levels of 5-FU metabolism enzymes have been studied widely in many solid tumors, no